2018
DOI: 10.2478/rrlm-2018-0004
|View full text |Cite
|
Sign up to set email alerts
|

Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients

Abstract: Background:The aim of the study was to determine the utility of plasma NfH in correlation with serum hsCRP for severity and short-term functional outcome prediction after ischemic stroke.Methods: 124 patients and 40 healthy controls were enrolled, serial plasma neurofilament heavy chains and hsCRP concentrations were measured and evaluated for TOAST subtype, stroke severity and functional outcome at discharge.Results: Serum level of hsCRP was significantly higher in patients versus controls (p<0.05) with no di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
1
1
Order By: Relevance
“…In a recent publication, we showed that the plasma level of neurofilament heavy chains (NfH), a possible marker of neuronal destruction, was significantly higher on day 5 after the onset of the disease, in a positive association with mRS ≥3 at discharge. [ 41 ] However, in the present analysis, significantly higher levels of NfH [median: 159.3 (IQR: 23.5–384.2) ng/ml] were found in patients with higher degree of disability in daily life activity (BI ≤80) compared with patients with BI >80 [median: 26.5 (IQR: 23.5–267.9) ng/ml] (data not shown).…”
Section: Discussioncontrasting
confidence: 69%
“…In a recent publication, we showed that the plasma level of neurofilament heavy chains (NfH), a possible marker of neuronal destruction, was significantly higher on day 5 after the onset of the disease, in a positive association with mRS ≥3 at discharge. [ 41 ] However, in the present analysis, significantly higher levels of NfH [median: 159.3 (IQR: 23.5–384.2) ng/ml] were found in patients with higher degree of disability in daily life activity (BI ≤80) compared with patients with BI >80 [median: 26.5 (IQR: 23.5–267.9) ng/ml] (data not shown).…”
Section: Discussioncontrasting
confidence: 69%
“…However, a number of adverse effects have been observed for vitamin E. Very high dosages of vitamin E (44 mg/kg body weight) increased blood pressure in spontaneously hypertensive stroke prone (SHRSP) rats [ 95 ]. There was also a rise in: phosphorylated neurofilament H protein, a prognostic marker of neurological disorders [ 96 ] and acute ischemic stroke [ 97 ]; glial fibrillary acidic protein associated with AD [ 98 ]; and cathepsin D in the CNS [ 95 ]. A study investigating the neuroinflammatory response following ischemic stroke in α-TTP-deficient mice treated with an α-TP diet (1680 IU/d) observed an exacerbation of ischemic stroke injury, due to supraphysiological brain injury accompanied by an increase in markers of oxidative injury and neurodegeneration [ 99 ].…”
Section: Vitamin E Can Fuel the Pathogenesis Of Neurodegenerative Diseasesmentioning
confidence: 99%